NCT06560385Terminated early
Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula
A Pilot, Double-blind, Randomised, Placebo-controlled Trial on the Efficacy of a Synbiotic Formula (BLHK03) in Alleviating Chemotherapy-induced Alopecia (CIA) in Breast Cancer Patients
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Terminated early
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- GenieBiome Limited
- Participants (registry)
- 7
- Start
- September 2024
- Primary completion
- August 2025
- Study completion
- August 2025
- Last registry update
- September 2026
- Countries
- Hong Kong
Conditions studied: Breast Cancer, Hair Loss
Interventions: BLHK03, Active placebo
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.